STRS Ohio’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-264,700
| Closed | -$328K | – | 1950 |
|
|
2024
Q1 | $328K | Buy |
264,700
+71,700
| +37% | +$88.8K | ﹤0.01% | 1411 |
|
|
2023
Q4 | $202K | Buy |
193,000
+138,900
| +257% | +$145K | ﹤0.01% | 1555 |
|
|
2023
Q3 | $370K | Hold |
54,100
| – | – | ﹤0.01% | 1385 |
|
|
2023
Q2 | $561K | Buy |
54,100
+4,200
| +8% | +$43.6K | ﹤0.01% | 1213 |
|
|
2023
Q1 | $403K | Buy |
49,900
+13,500
| +37% | +$109K | ﹤0.01% | 1409 |
|
|
2022
Q4 | $573K | Buy |
36,400
+16,500
| +83% | +$260K | ﹤0.01% | 1250 |
|
|
2022
Q3 | $313K | Buy |
19,900
+2,000
| +11% | +$31.5K | ﹤0.01% | 1481 |
|
|
2022
Q2 | $249K | Buy |
+17,900
| New | +$249K | ﹤0.01% | 1541 |
|
|
2021
Q4 | – | Sell |
-6,700
| Closed | -$120K | – | 2179 |
|
|
2021
Q3 | $120K | Sell |
6,700
-10,200
| -60% | -$183K | ﹤0.01% | 1908 |
|
|
2021
Q2 | $296K | Buy |
+16,900
| New | +$296K | ﹤0.01% | 1722 |
|
|
2017
Q2 | – | Sell |
-21,100
| Closed | -$629K | – | 1926 |
|
|
2017
Q1 | $629K | Buy |
+21,100
| New | +$629K | ﹤0.01% | 1220 |
|
|
2016
Q4 | – | Sell |
-8,100
| Closed | -$207K | – | 1910 |
|
|
2016
Q3 | $207K | Buy |
8,100
+5,100
| +170% | +$130K | ﹤0.01% | 1544 |
|
|
2016
Q2 | $55K | Buy |
3,000
+1,100
| +58% | +$20.2K | ﹤0.01% | 1754 |
|
|
2016
Q1 | $36K | Hold |
1,900
| – | – | ﹤0.01% | 1792 |
|
|
2015
Q4 | $51K | Buy |
+1,900
| New | +$51K | ﹤0.01% | 1790 |
|